Prescription Drug User Fee Act (PDUFA)
The Issue
The Prescription Drug User Fee Act (PDUFA), first enacted in 1992 and revised in 1997 and 2002, is a program under which the pharmaceutical/biotechnology industry pays certain "user fees" to the Food and Drug Administration (FDA). In return, the FDA has reduced the approval time for New Drug Application and Biological License Applications.
Our Position
We monitor the application of PDUFA at the FDA and support ongoing efforts to ensure quick but sufficient reviews of new drugs.
About MassBio
MassBio, founded in 1985, is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Latest Updates
- March 18, 2010 Sandra K. Russell Derby Day Benefit for Mito
- March 18, 2010 BD's Career Fair Open House
- March 18, 2010 MassBio Announces New Collaboration with UPS
- March 16, 2010 *NEW* 2 Day Seminar: Industry Knowledge for Non-Scientists
- March 15, 2010 Cubist President and CEO Michael Bonney Named MassBio Innovative Leadership Award Recipient